Regional Pharmacovigilance Unit, Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska University Hospital, Huddinge, Karolinska Institutet, Stockholm, Sweden.
Drugs Aging. 2009;26(7):595-606. doi: 10.2165/11315790-000000000-00000.
Adverse drug reactions (ADRs) are common in elderly patients. There are various reasons for this, including age- and disease-related alterations in pharmacokinetics and pharmacodynamics as well as the common practice of polypharmacy. The decline in renal function in elderly patients may also predispose them to pharmacological ADRs (type A, augmented). Patients receiving home healthcare may be at even higher risk.
To study ADRs as a cause of acute hospital admissions in a defined cohort of elderly patients (aged >or=65 years) registered to receive home healthcare services, with special reference to impaired renal function as a possible risk factor.
This was a retrospective study of 154 elderly patients aged >or=65 years admitted to the emergency department of a university hospital in Stockholm, Sweden, in October-November 2002. Estimated creatinine clearance (eCL(CR)) was calculated from the Cockcroft-Gault formula, and estimated glomerular filtration rate (eGFR) by the Modification of Diet in Renal Disease (MDRD) equation. ADRs were defined according to WHO criteria. All medications administered to patients at admission and at discharge were collated. These and other data were collected from computerized hospital records.
ADRs were judged to contribute to or be the primary cause of hospitalization in 22 patients, i.e. 14% of 154 patients registered to receive home healthcare. Eleven of the 22 patients were women. All but one ADR were type A. Excessive doses or drugs unsuitable in renal insufficiency were present in seven patients in the ADR group compared with only four patients in the group without ADRs (p = 0.0001). Patients with ADRs did not differ significantly from those without ADRs in relation to age, plasma creatinine, eCL(CR), weight or number of drugs prescribed at admission. However, women with ADRs were significantly older than women without ADRs (mean +/- SD age 88.8 +/- 5.7 years vs 82.5 +/- 8.0 years, respectively; p = 0.014) and had significantly lower mean +/- SD eCL(CR) values (25.5 +/- 10.8 and 37.1 +/- 17.1 mL/min, respectively; p = 0.035). Median MDRD eGFR was significantly higher than median eCL(CR) (59 [range 6-172] mL/min/1.73 m2 vs 38 [range 5-117] mL/min, respectively; p = 0.0001).
In elderly patients registered to receive home healthcare, 14% of hospital admissions were primarily caused by ADRs. One-third of these ADRs were related to impaired renal function, generally in very old women. These ADRs may be avoided by close monitoring of renal function and adjustments to pharmacotherapy (drug selection and dose), particularly in very elderly women.
不良反应(ADR)在老年患者中很常见。这有多种原因,包括年龄和疾病相关的药代动力学和药效学改变以及普遍的多药治疗。老年患者肾功能下降也可能使他们易发生药理 ADR(A型,增强型)。接受家庭保健的患者风险甚至更高。
研究因不良反应导致的在特定老年患者(年龄> = 65 岁)队列中急性住院的原因,这些患者接受家庭保健服务,特别关注肾功能损害作为可能的危险因素。
这是对 2002 年 10 月至 11 月在瑞典斯德哥尔摩一所大学医院急诊科收治的 154 名年龄> = 65 岁的老年患者进行的回顾性研究。根据 Cockcroft-Gault 公式计算估计的肌酐清除率(eCL(CR)),并根据肾脏病饮食改良试验(MDRD)方程计算估计的肾小球滤过率(eGFR)。根据世界卫生组织标准定义不良反应。将入院时和出院时给予患者的所有药物进行整理。这些和其他数据从计算机化的医院记录中收集。
22 名患者的不良反应被判断为导致或成为住院的主要原因,即接受家庭保健服务的 154 名患者中有 14%。这 22 名患者中有 11 名是女性。除了 1 例以外,所有不良反应均为 A 型。与无不良反应组相比,不良反应组中有 7 名患者存在剂量过大或肾功能不全时不适用的药物,而无不良反应组中只有 4 名患者(p = 0.0001)。有不良反应的患者与无不良反应的患者在年龄、血浆肌酐、eCL(CR)、体重或入院时开具的药物数量方面无显著差异。然而,有不良反应的女性明显比无不良反应的女性年龄大(平均 +/- 标准差年龄 88.8 +/- 5.7 岁与 82.5 +/- 8.0 岁,分别;p = 0.014),eCL(CR)值明显更低(平均 +/- 标准差值 25.5 +/- 10.8 和 37.1 +/- 17.1 mL/min,分别;p = 0.035)。MDRD eGFR 的中位数明显高于 eCL(CR)的中位数(59 [范围 6-172] mL/min/1.73 m2与 38 [范围 5-117] mL/min,分别;p = 0.0001)。
在接受家庭保健的老年患者中,14%的住院是由不良反应引起的。其中三分之一的不良反应与肾功能损害有关,通常发生在非常年老的女性中。通过密切监测肾功能并调整药物治疗(药物选择和剂量),特别是在非常年老的女性中,可以避免这些不良反应。